Filing Flows › Integra Lifesciences Holdings (IART) › Recalls, complaints & regulation
Integra Lifesciences Holdings (IART): recalls and clinical trials
Integra Lifesciences Holdings (IART) beyond its filings: 16 recalls in the last 12 months (94 in five years, 10 Class I); 6 active clinical trials.
Latest recalls
- 2026-07-15 · FDA device · OmniTract Surgical Retractor System, which includes 633 of the firm s product codes.
- 2026-05-20 · FDA device · Codman CerebroFlo EVD Catheter with Endexo Technology. Contains 5 sets. Product ID: 37.550.501. The CerebroFlo EVD Catheter is a 3.3 mm diameter (10 Fr.), 35
- 2026-04-29 · FDA device · CUSA Clarity C7000 Console, Software Version: 2.1.1.909. Ultrasonic surgical aspirator system.
- 2026-04-22 · FDA device · Cytal Burn Matrix 10x15 cm. Product ID: BMM1015.
- 2026-04-22 · FDA device · Cytal Wound Matrix 2-Layer 5x5 cm. Product ID: WSM0505.
- 2026-04-22 · FDA device · Cytal Burn Matrix 7x10 cm. Product ID: BMM0710.
- 2026-04-22 · FDA device · Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710.
- 2026-04-22 · FDA device · Cytal Wound Matrix 2-Layer 10x15 cm. Product ID: WSM1015.
Integra Lifesciences Holdings' latest quarter
Integra Lifesciences Holdings, Q3 2026: revenue $411M (+2% year over year), operating margin 4.6%, net earnings $14.9M, operating cash flow $96.0M. The chart follows the revenue to costs, profit and cash.
Questions
Has Integra Lifesciences Holdings had any recalls?
94 recalls on file over five years from the FDA, CPSC and NHTSA; 16 in the last 12 months.
How many clinical trials does Integra Lifesciences Holdings have?
6 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.